Transactions
41
Insider / Vaxcyte, Inc.
Wassil Jim
CHIEF OPERATING OFFICER at Vaxcyte, Inc.
- Company
- Vaxcyte, Inc.
- Ticker
- PCVX
- First filing on record
- March 2, 2026
- Latest trade on record
- October 5, 2026
- SEC filings
- EDGAR ↗
Wassil Jim, CHIEF OPERATING OFFICER at Vaxcyte, Inc., has disclosed 41 transactions in PCVX since March 2, 2026: 0 purchases (0 open-market buys) and 28 sales, worth about $4.4M at the reported prices. The latest was filed October 7, 2026, 2 days after the trade; 6 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
28
Avg. disclosure lag
2.1d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Wassil Jim made no purchases and 28 sales worth $3.9M, plus 13 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Wassil Jim has traded 1 stock on record; the largest by dollars is PCVX.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
2 of 11 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 21 | 45,087 | $3.1M |
| M | Option exercise or conversion | 10 | 50,532 | $135K |
| F | Shares withheld for tax | 7 | 12,946 | $788K |
| A | Grant or award | 3 | 90,713 | $315K |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 41 | 0 | 28 · $3.9M |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| PCVX | Option / conversion M | October 5, 2026 | October 7, 2026 | 2d | 18,000 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| PCVX | Sell S | October 5, 2026 | October 7, 2026 | 2d | 18,000 | $87 | $1.6M | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Option / conversion M | October 5, 2026 | October 7, 2026 | 2d | 18,000 | $5 | $96K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Option / conversion M | October 1, 2026 | October 2, 2026 | 1d | 2,250 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| PCVX | Sell S | October 1, 2026 | October 2, 2026 | 1d | 95 | $57 | $5,424 | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | October 1, 2026 | October 2, 2026 | 1d | 2,155 | $57 | $122K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Option / conversion M | October 1, 2026 | October 2, 2026 | 1d | 2,250 | $5 | $12K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | September 9, 2026 | September 9, 2026 | 0d | 1,334 | $60 | $79K | Form 4 ↗ | ||
| PCVX | Sell F | September 8, 2026 | September 9, 2026 | 1d | 5,459 | $60 | $330K | Form 4 ↗ | ||
| PCVX | Sell S | September 4, 2026 | September 9, 2026 | 5d | 1,381 | $61 | $84K | late | Form 4 ↗ | |
| PCVX | Option / conversion M | September 1, 2026 | September 2, 2026 | 1d | 2,250 | — | — | derivative | Form 4 ↗ | |
| PCVX | Sell F | September 2, 2026 | September 2, 2026 | 0d | 1,432 | $62 | $88K | Form 4 ↗ | ||
| PCVX | Sell S | September 1, 2026 | September 2, 2026 | 1d | 303 | $61 | $19K | Form 4 ↗ | ||
| PCVX | Sell S | September 1, 2026 | September 2, 2026 | 1d | 924 | $61 | $56K | Form 4 ↗ | ||
| PCVX | Sell S | September 1, 2026 | September 2, 2026 | 1d | 713 | $61 | $44K | Form 4 ↗ | ||
| PCVX | Sell S | September 1, 2026 | September 2, 2026 | 1d | 1,537 | $61 | $94K | Form 4 ↗ | ||
| PCVX | Option / conversion M | September 1, 2026 | September 2, 2026 | 1d | 2,250 | $5 | $12K | Form 4 ↗ | ||
| PCVX | Sell F | August 31, 2026 | September 2, 2026 | 2d | 1,273 | $61 | $77K | Form 4 ↗ | ||
| PCVX | Option / conversion M | August 3, 2026 | August 5, 2026 | 2d | 2,250 | — | — | 10b5-1 planderivative | Form 4 ↗ | |
| PCVX | Sell S | August 3, 2026 | August 5, 2026 | 2d | 1,389 | $54 | $75K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | August 3, 2026 | August 5, 2026 | 2d | 861 | $54 | $46K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Option / conversion M | August 3, 2026 | August 5, 2026 | 2d | 2,250 | $5 | $12K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 516 | — | — | late10b5-1 planderivative | Form 4 ↗ | |
| PCVX | Sell S | July 1, 2026 | July 6, 2026 | 5d | 6 | $58 | $347 | late10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | July 1, 2026 | July 6, 2026 | 5d | 456 | $57 | $26K | late10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | July 1, 2026 | July 6, 2026 | 5d | 1,788 | $56 | $100K | late10b5-1 plan | Form 4 ↗ | |
| PCVX | Option / conversion M | July 1, 2026 | July 6, 2026 | 5d | 516 | $5 | $2,761 | late10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | June 1, 2026 | June 3, 2026 | 2d | 301 | $50 | $15K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | June 1, 2026 | June 3, 2026 | 2d | 1,949 | $49 | $96K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | May 1, 2026 | May 1, 2026 | 0d | 2,250 | $57 | $128K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | April 1, 2026 | April 3, 2026 | 2d | 838 | $59 | $49K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | April 1, 2026 | April 3, 2026 | 2d | 1,412 | $58 | $82K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | March 10, 2026 | March 11, 2026 | 1d | 4,968 | $59 | $294K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell S | March 10, 2026 | March 11, 2026 | 1d | 2,427 | $58 | $142K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Sell F | March 9, 2026 | March 11, 2026 | 2d | 975 | $59 | $58K | 10b5-1 plan | Form 4 ↗ | |
| PCVX | Other A | February 26, 2026 | March 2, 2026 | 4d | 53,566 | — | — | derivative | Form 4 ↗ | |
| PCVX | Sell F | March 2, 2026 | March 2, 2026 | 0d | 1,009 | $62 | $63K | Form 4 ↗ | ||
| PCVX | Sell F | February 28, 2026 | March 2, 2026 | 2d | 898 | $62 | $56K | Form 4 ↗ | ||
| PCVX | Sell F | February 27, 2026 | March 2, 2026 | 3d | 1,900 | $62 | $117K | Form 4 ↗ | ||
| PCVX | Other A | February 27, 2026 | March 2, 2026 | 3d | 5,102 | $62 | $315K | Form 4 ↗ | ||
| PCVX | Other A | February 26, 2026 | March 2, 2026 | 4d | 32,045 | — | — | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| October 7, 2026 | Form 4 | 0001813798-26-000023 | 3 | published | EDGAR ↗ |
| October 2, 2026 | Form 4 | 0001813798-26-000021 | 4 | published | EDGAR ↗ |
| September 9, 2026 | Form 4 | 0001813798-26-000019 | 3 | published | EDGAR ↗ |
| September 2, 2026 | Form 4 | 0001813798-26-000017 | 8 | published | EDGAR ↗ |
| August 5, 2026 | Form 4 | 0001813798-26-000015 | 4 | published | EDGAR ↗ |
| July 6, 2026 | Form 4 | 0001813798-26-000013 | 5 | published | EDGAR ↗ |
| June 3, 2026 | Form 4 | 0001813798-26-000011 | 2 | published | EDGAR ↗ |
| May 1, 2026 | Form 4 | 0001813798-26-000010 | 1 | published | EDGAR ↗ |
| April 3, 2026 | Form 4 | 0001813798-26-000008 | 2 | published | EDGAR ↗ |
| March 11, 2026 | Form 4 | 0001813798-26-000005 | 3 | published | EDGAR ↗ |
| March 2, 2026 | Form 4 | 0001813798-26-000003 | 6 | published | EDGAR ↗ |
Other insiders at Vaxcyte, Inc.
- PICKERING GRANT CHIEF EXECUTIVE OFFICER 32 rows
- Cowan Elvia SVP, Finance & CAO 24 rows
- GUGGENHIME ANDREW PRESIDENT AND CFO 21 rows
- Dhaliwal Harpreet S. Chief Technical Ops Officer 12 rows
- Gilbert Halley E Director 7 rows
- BRANDICOURT OLIVIER Director 6 rows
- Drapeau Anne S Director 2 rows
- Furey John Director 2 rows
- Jodar Luis Chief Medical Officer 2 rows
- Lee Jacks Director 2 rows
Everyone on file, with contracts and lobbying under the company's name: Vaxcyte, Inc..
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Rule 10b5-1 trading plans The plan must be set up when the insider has no important non-public information.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 11 | 41 | March 2, 2026 | October 7, 2026 | Form 4 list on EDGAR |
Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.